Product News

Ceva launches Marboxidin chewable tablets

Marboxidin suitable for treatment of micro-organisms susceptible to marbofloxacin, including skin and soft tissue infections (cats and dogs), respiratory tract infections (cats and dogs) and urinary tract infections (dogs).

Ceva Animal Health has launched Marboxidin chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin.

MarbodixinMarboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg). Marboxidin is part of Ceva's Cevolution range of high quality anti-infectives.

Conditions treatable with this new product include:

  • skin and soft tissue infections (in cats and dogs)
  • respiratory tract infections (in dogs and cats)
  • urinary tract infections (in dogs)

Containing marbofloxacin as its active ingredient, Marboxidin benefits from taste-masking lipid coating technology to ensure that its bitterness is not detected.

In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food (Palatability study number LAV028/2012 in Marboxidin MA file).

For further details, contact your Ceva territory manager or call the customer support team on (01494) 781510.

Share |

You must be logged in to comment on this article

Already an account?

Remember me

Forgot your password?
Create an account

Follow vetsonline on In Youtube Twitter Facebook Google Rss



The BVA and BSAVA are currently urging owners to avoid smoking around animals. Have you ever discussed your clients' smoking habits and the effect it could have on their pets?


Keep abreast of the latest veterinary news and views. The vetsonline newsletter is sent out weekly, free of charge, to all subscribers.
* indicates required


This website uses cookies to optimise your user experience. Click here for further details or to manage your cookie preferences.